Ontex Group N.v. · EURONEXT:ONTEX
Ontex — Q3 2026 Earnings Presentation
22 slides from Ontex's earnings presentation, Oct 28, 2026
Slide 1: Q3 2026 results
Q3 2026 results October 28, 2026
Slide 2: Disclaimer
Disclaimer Forward-looking statements This presentation may include forward-looking statements. Forward-looking statements are statements regarding or based upon our management’s current intentions, beliefs or expectations relating to, among other things, Ontex’s future results of operations, financ
Slide 3: Strategic update
Strategic update 3
Slide 4: Fundamental transformation started around 4 major shifts
Fundamental transformation started articulated around 4 major shifts 1 2 3 4 Increase structural Reset the approach Adopt a more productivity by in North America to Accelerate adult targeted approach launching an prioritize care growth in to protect baby and ambitious Focus to profitability over Eur
Slide 5: Making solid progress on ambitious Focus to Value program
1 Making solid progress on ambitious Focus to Value program Realization so far Key workstreams Q3 progress examples: Manufacturing > Production in Australia > Tampons plant €45M excellence to cease in Q4 right-sized by Q4 Logistics & > End-to-end planning > Optimizing healthcare i.e. 19% of planning
Slide 6: Business in Europe showing better profitability and resilience than total portfolio
Business in Europe showing better profitability and resilience than total portfolio Europe Overseas businesses Europe North > Non-European > European business America maintains double digit businesses margin- adj. EBITDA margin dilutive YtD Revenue YtD 2026 > Strategic initiatives > Mix dynamic prov
Slide 7: Q3 2026 highlights
Q3 2026 highlights 7
Slide 8: Q3 impacted by steep increase in input costs
Q3 impacted by steep increase in input costs Revenue Adj. EBITDA margin Leverage ratio Liquidity €428M 6.1% 3.75x €272M -3.9% YoY -5.3pp YoY vs 3.29x at 12/25 vs €240M at 12/25 -0.1% QoQ -3.2pp QoQ vs 3.22x at 06/26 vs €279M at 06/26 €1,283M YtD 8.1% YtD -3.2% YoY -2.2pp 8 YoY = Year on Year, QoQ =
Slide 9: Stabilizing revenue sequentially; marked drop in margin
Stabilizing revenue sequentially Marked drop in margin with pricing lagging input cost inflation Revenue evolution Adj. EBITDA and margin evolution (Continuing operations, in €M) (Continuing operations, in €M) 451 11.2% 11.4% 445 436 430 426 428 428 Feminine 56 60 care 58 54 53 54 54 9.1% 9.2% 51 51
Slide 10: Raw material indices reaching a peak in Q2, affecting cost from Q3
Raw material indices reaching a peak in Q2, affecting cost as from Q3 mainly Although slightly down now, remaining at high level versus year start Index evolution [1] (for Europe, relative to 12/25 in €/t) Q3 impact Q4 impact & beyond 200% > Oil-based indices peaked > Indices have come down >50% in
Slide 11: Q3 2026 financials
Q3 2026 financials 11
Slide 12: Revenue down YoY on soft baby market and lower volumes
Revenue down YoY, on persisting soft baby market, and lower volumes overseas and in feminine care CMF [1] Q3 revenue YoY (in €M) > Volumes down 5% YoY 445 -16 Adult care volumes stable, reflecting solid demand in healthcare in Europe, offsetting weaker sales in retail channel 426 428 -7 +2 -4% +3
Slide 13: Steep increase in input costs and lower revenue drive adj. EBITDA down
Steep increase in input costs and lower revenue drive adj. EBITDA down despite solid savings delivery Q3 adj. EBITDA YoY (in €M) > Lower volume and limited initial pricing effect leads to €(7)M revenue impact 51 -7 -18 > Net costs up by €(18)M, due to full impact of input cost increase, partly offse
Slide 14: Net debt further reduced; strong liquidity position preserved
Net debt further reduced Strong liquidity position continues to be preserved Net debt and leverage ratio evolution (Total Group, in €M) 3.75x 3.29x 3.36x > Net debt reduced despite lower adj. EBITDA, 3.22x thanks to good WC management and capex 2.72x 2.68x 2.70x discipline 2.46x 612 656 > Leverage c
Slide 15: Subsequent event: Russia operations under interim administration
Subsequent event Russia operations under interim administration > Assets will be deconsolidated as from October > Limited impact on the Group’s financial position and performance Net debt reduces by €10M pro forma Ontex Russia P&L contribution in Q4 Employees ~350 estimated at ~€2M Revenue ~5% o
Slide 16: Going forward
Going forward 16
Slide 17: Forecast impacted by prolonged input cost pressure
Forecast impacted by prolonged input cost pressure combined with slower than expected pricing and volume ramp up Full year adj. EBITDA outlook evolution (in €M) Outlook revision triggered by: 165-180 > Persisting geopolitical negative environment 143-148 Cost inflation Pricing Diesel and raw mater
Slide 18: Q4 adj. EBITDA expected to return to H1 level
Q4 adj. EBITDA expected to return to H1 level and stable to growing YoY Adj. EBITDA outlook bridge from 2026 Q3 to Q4 (in €M) Improvement from Q3 to Q4: 39-44 > Slightly lower input cost level Russia Other decons. Volume > Confirmed pricing impact & mix growth 26 Higher > Better volume & mix (season
Slide 19: Outlook revised
Outlook revised Adj. EBITDA Free cash flow Leverage ratio €143-148M €(10)-0M ≤3.75X vs €176M vs €(25)M vs 3.3x in 2025 in 2025 end 2025 previously previously previously €165-180M €(25)-(10)M <3.5x 19
Slide 20: Priorities for Q4
Priorities for Q4 I Preserve financial flexibility through disciplined cash management while executing the transformation agenda II Continue pricing actions to offset higher input costs Accelerate Focus to Value program to deliver additional productivity and efficiency III gains 20
Slide 21: Q&A
Q&A 21
Slide 22: Ontex—Here for you.
Ontex— Here for you.